 double-blind random trial hydrocortison acut hepat failur acut hepat failur studi group acut hepat failur studi group ahfsg double-blind random evalu hydrocortison patient acut hepat failur juli august period medic center unit canada trial total patient elig studi analysi eighteen patient mg hydrocortison day patient mg hydrocortison day therapeut effect hydrocortison surviv rate placebo versu mg versu mg hydrocortison day fulmin hepat drug hepatotox non-a non-b hepat prognosi fulmin differ signific serum alpha-fetoprotein modest prognost valu surviv ahfsg corticosteroid use acut hepat failur hepat encephalopathi